These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2178854)
21. Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Williams MF; Dukes GE; Heizer W; Han YH; Hermann DJ; Lampkin T; Hak LJ Pharm Res; 1992 Sep; 9(9):1190-4. PubMed ID: 1409403 [TBL] [Abstract][Full Text] [Related]
22. Anti-secretory effects and pharmacokinetics of low dose ranitidine. Koss MA; Hogan DL; Lane J; Steinbach JH; Isenberg JI Aliment Pharmacol Ther; 1993 Aug; 7(4):417-22. PubMed ID: 8218756 [TBL] [Abstract][Full Text] [Related]
23. Effect of Sustained Elevated Gastric pH Levels on Gefitinib Exposure. Tang W; Tomkinson H; Masson E Clin Pharmacol Drug Dev; 2017 Sep; 6(5):517-523. PubMed ID: 28176470 [TBL] [Abstract][Full Text] [Related]
24. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine. Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050 [TBL] [Abstract][Full Text] [Related]
25. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
26. [The effect of ranitidine on gastric pH measured by continuous monitoring over 24 hours in healthy subjects. Comparison of 2 methods of administration: 150 mg morning and night, vs 300 mg in a single dose at night]. Bonfils S; Guedon C; Vallot T; Congard P; Garcia del Risco F; Galmiche JP; Denis P; Pappo M Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):221-5. PubMed ID: 3207350 [TBL] [Abstract][Full Text] [Related]
27. Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy. Maurer AH; Krevsky B; Knight LC; Brown K J Nucl Med; 1996 May; 37(5):818-22. PubMed ID: 8965152 [TBL] [Abstract][Full Text] [Related]
28. A comparison of gastric emptying rate after cimetidine and ranitidine measured by applied potential tomography. Mushambi MC; Trotter TN; Barker P; Rowbotham DJ Br J Clin Pharmacol; 1992 Sep; 34(3):278-80. PubMed ID: 1389955 [TBL] [Abstract][Full Text] [Related]
29. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Merki HS; Wilder-Smith CH Gastroenterology; 1994 Jan; 106(1):60-4. PubMed ID: 8276209 [TBL] [Abstract][Full Text] [Related]
30. The effect of pH change on the gastric emptying of liquids measured by electrical impedance tomography and pH-sensitive radiotelemetry capsule. Chaw CS; Yazaki E; Evans DF Int J Pharm; 2001 Oct; 227(1-2):167-75. PubMed ID: 11564551 [TBL] [Abstract][Full Text] [Related]
31. Lubiprostone neither decreases gastric and small-bowel transit time nor improves visualization of small bowel for capsule endoscopy: a double-blind, placebo-controlled study. Hooks SB; Rutland TJ; Di Palma JA Gastrointest Endosc; 2009 Nov; 70(5):942-6. PubMed ID: 19577749 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of the effect of cimetidine and ranitidine on the rate of gastric emptying of liquid and solid test meals in man. Houghton LA; Read NW Aliment Pharmacol Ther; 1987 Oct; 1(5):401-8. PubMed ID: 2979683 [TBL] [Abstract][Full Text] [Related]
33. [Antisecretory effect of the H2-histamine receptor antagonist ranitidine in water-soluble tablets and film-coated tablets. Results of a randomized, placebo-controlled crossover study in humans]. Witzel L; Röhmel J Arzneimittelforschung; 1990 Apr; 40(4):457-9. PubMed ID: 2192716 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of ranitidine following oral administration with ascending doses and with multiple-fixed doses. Garg DC; Eshelman FN; Weidler DJ J Clin Pharmacol; 1985 Sep; 25(6):437-43. PubMed ID: 4056078 [TBL] [Abstract][Full Text] [Related]
35. Gastric fluid volume, pH, and emptying in elective inpatients. Influences of narcotic-atropine premedication, oral fluid, and ranitidine. Maltby JR; Koehli N; Ewen A; Shaffer EA Can J Anaesth; 1988 Nov; 35(6):562-6. PubMed ID: 2904839 [TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects. Doan TT; Wang Q; Griffin JS; Lukasik NL; O'Dea RF; Pan WJ Am J Health Syst Pharm; 2001 Aug; 58(16):1512-9. PubMed ID: 11515348 [TBL] [Abstract][Full Text] [Related]
37. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine. Merki HS; Halter F; Wilder-Smith CH Gastroenterology; 1993 Sep; 105(3):748-54. PubMed ID: 8103027 [TBL] [Abstract][Full Text] [Related]
38. Detection of drug effects on gastric emptying and contractility using a wireless motility capsule. Rozov-Ung I; Mreyoud A; Moore J; Wilding GE; Khawam E; Lackner JM; Semler JR; Sitrin MD BMC Gastroenterol; 2014 Jan; 14():2. PubMed ID: 24383478 [TBL] [Abstract][Full Text] [Related]
39. The effect of preoperative oral fluid and ranitidine on gastric fluid volume and pH. Sutherland AD; Maltby JR; Sale JP; Reid CR Can J Anaesth; 1987 Mar; 34(2):117-21. PubMed ID: 3829296 [TBL] [Abstract][Full Text] [Related]